How to Choose a Ketamine Provider
What good care looks like and the questions worth asking
Last updated: August, 2026
Most people arrive at ketamine after a long stretch of trying. Medications that flattened more than they lifted. Therapy that helped and then plateaued. A slow accumulation of understanding that never quite reached the part of you that needed reaching. So when you find a provider, there's a strong pull to simply feel relieved and say yes.
I want to offer something else first. Not caution exactly — I work with this medicine and I've watched it change lives. But ketamine is one of the few treatments where the quality of the container around it matters as much as the substance inside it. The same dose, in two different settings, can produce two entirely different outcomes. One becomes a turning point. The other becomes a strange afternoon you don't quite know what to do with, or occasionally something harder than that.
The difference is rarely the medicine. It's almost always the preparation, the supervision, and what happens in the days afterward. This is a guide to telling those apart. I'm a licensed marriage and family therapist who provides ketamine-assisted psychotherapy, and I don't prescribe — which means I have no stake in which model you choose. This is written to help you evaluate the care in front of you, not to sell you a version of it.
First: know which model you're being offered
"Ketamine therapy" describes at least four quite different things. People often don't realize they're choosing between them.
Clinic-based infusion (IV or intramuscular). Administered in a medical setting, usually by an anesthesiologist, nurse anesthetist, or psychiatric provider. Vital signs monitored. Typically the highest level of medical oversight. Whether any psychological support is included varies enormously — some clinics offer a quiet room and a ride home, others have therapists integrated into the protocol. This is the single most important question to ask an infusion clinic, and the answer is often "no."
At-home sublingual via telehealth. Prescribed remotely, lozenges or troches mailed to you, dosing at home. The most accessible and least expensive route, and the fastest-growing. Federal telemedicine flexibilities currently permit prescribing controlled substances without a prior in-person visit; those flexibilities have been extended repeatedly and are set to run through the end of 2026, with permanent rules still being written. State law adds another layer. The practical consequence is that quality varies more in this category than in any other — from careful programs with real screening and integration support, to services where you'll speak to someone for fifteen minutes and receive a package.
Ketamine-assisted psychotherapy (KAP). A therapist is present during the medicine session, or immediately available, with preparation sessions before and integration sessions after. The prescriber and the therapist may be the same person or, more often, two people working in collaboration. The medicine is treated as one part of a therapeutic process rather than as the treatment itself.
Spravato (esketamine). An FDA-approved nasal spray for treatment-resistant depression, and the only one of these operating under a formal federal safety program. It can only be given in a certified healthcare setting, never dispensed for home use, and patients must be monitored on site by a healthcare provider for at least two hours after every dose.
That last requirement is worth holding onto. It's the clearest existing benchmark for what supervised ketamine care looks like when a regulator defines it — and it's a useful reference point when you're evaluating a program that isn't required to meet it.
Second: Who is actually treating you?
Ketamine care involves two distinct roles, and they're often filled by different people. A prescriber — MD, DO, nurse practitioner, or physician assistant — evaluates you medically and authorizes the medicine. A therapist — psychologist, LMFT, LCSW, or LPCC — does the psychological work before, during, and after. In some settings a nurse or CRNA administers and monitors. When a program is vague about who does what, it's usually because one of these roles isn't filled.
There's something worth naming plainly about experience in this field: it's young. Nobody has thirty years of ketamine-assisted psychotherapy behind them, because the work hasn't existed that long. So the question isn't really how many years — it's what someone is standing on.
What that actually looks like:
Depth in the underlying discipline. A therapist's grounding in trauma work is what carries a difficult session, not their psychedelic training. Someone with fifteen years of trauma therapy and two years of KAP is generally on firmer ground than the reverse. Ask what they did before this work.
Hours in the room, not hours in a classroom. Roughly how many medicine sessions have they sat? A weekend certificate and forty sessions of experience are very different things, and only one of them is training.
Formal training with a name attached. Programs like CIIS, Fluence, Polaris Insight Center, PRATI, IPI, or the MAPS-lineage trainings are substantive. Ask which one, how long it ran, and whether it included supervised practice. Note that no certification is legally required and none of them is a license — which is exactly why the question matters.
Ongoing consultation. This is the most revealing question on the list. Clinicians doing this work well are in regular consultation or peer supervision, because the material is genuinely hard to hold alone. Someone who isn't consulting anyone is either very experienced or not experienced enough to know they need it.
Honesty about hard sessions. Ask what a difficult session has looked like and what they did. Anyone with real hours has stories. An answer suggesting nothing difficult has ever happened means too few sessions, or not enough attention paid.
One thing worth saying clearly: a newer practitioner isn't a problem. A newer practitioner who won't say so is. Someone early in this work, with strong clinical grounding and active supervision, may serve you better than someone with more medicine hours and less depth underneath. What you're listening for is whether they can describe their own limits.
What adequate care includes
Whatever the model, these elements are what separate a treatment from a transaction.
A real screening. Not a checkbox form. A conversation covering your psychiatric history, current medications, blood pressure and cardiac history, substance use history, and any family history of psychosis or bipolar disorder. Ketamine i not appropriate for everyone. A provider who doesn't ask is a provider who doesn't know.
Informed consent that includes the difficult possibilities. Consent paperwork should describe dissociation, the potential for frightening or disorienting experiences, physical side effects including nausea and elevated blood pressure, and the risks associated with frequent long-term use. If the consent material reads like marketing, it isn't consent.
Someone present, or genuinely reachable. For at-home dosing this means a sober adult in the house, and a real phone number that a real clinician answers during your session window. Not a support inbox.
An emergency plan you've been told about in advance. What happens if your blood pressure spikes. What happens if you become frightened and can't come out of it. What happens at two in the morning three days later. You should not have to ask.
Preparation. At least one conversation, before any medicine, about what you're hoping for, what you're afraid of, and what you'll do when the experience turns unexpected. Preparation isn't a nicety. It's the strongest predictor of whether a hard passage becomes generative or simply frightening.
Integration. Structured support in the days and weeks after — because that's where the change consolidates or doesn't. The medicine opens something. What you do with the opening is the actual treatment.
A defined arc. How many sessions, spaced how far apart, with what checkpoints to assess whether it's working and what happens if it isn't. Open-ended prescribing with no review point is not a treatment plan.
Questions to ask before you commit
About the arc
How many sessions do you typically recommend, and how far apart?
How will we know whether this is working?
What happens if it isn't?
What does tapering or stopping look like?
About integration
What support is included after each session?
Do you provide integration therapy, or refer out?
What do you recommend for the first few days afterward?
About the practical
What's the total cost, including all sessions and follow-up?
What are your policies on refills and on requests for more frequent dosing?
Read these off a screen during a consultation call. A good provider will welcome them.
About the screening process
What does your intake assessment cover?
What conditions or histories would make you decline to treat someone?
Will you coordinate with my existing therapist or prescriber?
About the session
Who will be with me during dosing, and what are their credentials?
If I'm dosing at home, what are your requirements for having someone present?
How do I reach a clinician during the session if I need to?
What's the plan if I have a difficult experience?
Red flags
Any one of these is worth pausing over. Two or more, and I'd keep looking.
No meaningful psychiatric screening, or a screening consisting only of a form you fill out yourself.
No sitter requirement for at-home dosing. A program comfortable with you dosing alone in an empty house has made a decision about your safety that it shouldn't be making.
A prescribing consultation under twenty minutes, particularly if it's the only clinical contact before medicine arrives.
Automatic refills or subscription-style renewal without a clinical check-in. Ketamine has genuine abuse potential, and a business model built on uninterrupted supply is not aligned with your interests.
No emergency protocol, or vague answers when you ask for one.
No integration offered at all, and no referral when you ask about it.
Being told preparation and integration aren't really necessary. This is the clearest signal that you're being sold a substance rather than offered care.
Guaranteed outcomes. Nobody can promise you what will happen. Anyone who does is telling you something about their sales process, not their clinical judgment.
No willingness to coordinate with your existing therapist or prescriber.
Pressure to buy a package before you've had a full clinical conversation.
If your provider checks out
Then you're in good hands, and this article has done its job. Bring your questions to your preparation session, and let the people caring for you carry the structure.
If they don't
You have more choices than "proceed anyway" or "give up." You can ask for what's missing. Many providers will accommodate a request for a preparation conversation, or a sitter, or a check-in call, if you ask directly. You can find an integration therapist independently of your prescriber; a great many of us work exactly this way, and it doesn't require changing your medical provider. And you can do a meaningful amount of the preparation yourself: building the capacity to stay with intensity, designing your own container, knowing what to do when the experience turns hard, and protecting the days afterward from the rush to make meaning too quickly.
That last piece is what I teach. My preparation and integration course exists because the treatment has scaled faster than the care around it, and because the people most likely to benefit from this medicine are often the ones being handed the least support with it.
But whether you take it or not: ask the questions. Expect real answers. This medicine deserves a good container, and so do you.
This article is educational and is not medical advice. It doesn't replace the guidance of your prescriber or treating clinician, and it isn't a substitute for individual assessment. Regulations governing telehealth prescribing of controlled substances are in flux; verify current requirements in your state.
Meg Lear is a licensed marriage and family therapist practicing in Nevada City, California, specializing in ketamine-assisted psychotherapy.